Skip to content
Medical Health Aged Care

“This will save lives”: GPs welcome Victorian drug testing trial

Royal Australian College of GPs 2 mins read

Australia’s peak GP body the Royal Australian College of GPs (RACGP) has warmly welcomed Victoria introducing a drug testing trial.

It comes following Victorian Premier, Jacinta Allan, and Minister for Mental Health, Ingrid Stitt, today announcing an 18-month drug testing trial, commonly called “pill testing”, including mobile and fixed site services.

RACGP Victoria Chair, Dr Anita Munoz, said the announcement was a huge step forward.

“This will save lives,” she said.

“A drug testing trial will enable people to understand what they are actually taking, including young people experimenting with illicit drugs who have their whole lives ahead of them. Drug testing sites are also a great way of engaging with those who are using illicit drugs, including people in their teens and early 20’s at music festivals and other similar events. Trained staff at these services can talk to them free of judgment about why they are using drugs and outline the risks involved. Drug testing has been proven to work in other jurisdictions, it makes sense, and it saves lives.

“This is a victory for common sense and sound policy over tired rhetoric and a ‘war-on-drugs’ mentality that gets us nowhere. Alcohol and other drug use, whether it be illicit drug use at music festivals or people experiencing severe opioid dependence on drugs such as heroin, is a health issue.

“Earlier this year, we called on the Victorian Government to heed coronial recommendations to trial a drug testing service. The Government has not only listened to the College, and a host of other groups, but acted decisively to introduce mobile and fixed sites. It’s such a fantastic outcome. Drug testing is not about condoning illicit drug use, rather it’s a sensible harm reduction measure. There is no use pretending that people don’t use illicit drugs, it is a reality of life. So, let’s focus on minimising harm and keeping people as safe as possible."

RACGP Addiction Medicine spokesperson, Dr Marguerite Tracy, called for other states and territories to follow suit.

“This is fantastic news, and further evidence that momentum is building around Australia,” she said.

“In March this year, we welcomed Queensland becoming the first Australian jurisdiction to institute an ongoing drug testing or ‘pill testing’ service. The ACT has also successfully conducted drug testing at events such as music festivals and now has a fixed pill testing site. So, it is time for other states and territories to follow suit.  

“Every life is worth saving. And every day we delay is another day that people can experience overdoses and be hospitalised, or worse.”

RACGP spokespeople are available for comment.


Contact details:

Media team: 03 8699 0992 media@racgp.org.au

 

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 07/10/2024
  • 19:11
Royal Philips

Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia’s healthcare transformation strategy

October 7, 2024Jakarta, Indonesia and Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Siloam Hospitals Group, Indonesia’s leading private healthcare provider, have signed a Memorandum of Understanding (MoU) to advance AI capabilities and development in the healthcare sector in Indonesia.The strategic collaboration, in partnership with the Universitas Pelita Harapan (UPH) Medical Sciences Group, will focus on capacity building, knowledge sharing, and implementing advanced AI solutions. Leveraging Philips’ AI innovations, the collaboration will help transform clinical care and digital health, enhance healthcare delivery and make the healthcare infrastructure more sustainable. The goal is…

  • Medical Health Aged Care
  • 07/10/2024
  • 17:41
GE HealthCare

GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based…

  • Contains:
  • Medical Health Aged Care, Research Development
  • 07/10/2024
  • 14:03
Eastern Health

Eastern Health Clinician leading international autoimmune research

• Clinical Lead of the Eastern Health Multiple Sclerosis and Neuroimmunology Service, Dr Katherine Buzzard is co-chair of the scientific leadership group (SLG) leading an international database designed to study real-world outcomes in Myasthenia Gravis (MG) aimed at improving the quality of life for those battling the disease.• MG is a rare chronic autoimmune disorder whereby antibodies block the signaling between nerves and muscles, resulting in muscle weakness. It affects women and men of all ages.• MGBase is a global MG patient registry collecting longitudinal data to allow biostatisticians and clinicians to do statistical modelling and analysis to improve our…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.